Juan Pablo Arab on NAFLD public health policies in the Americas

Juan Pablo Arab on NAFLD public health polici...

Up next

Aleksander Krag on the utility of PEth for subclassifying individuals at risk of steatotic liver disease

Steatotic liver disease labels hinge on alcohol intake, but self-report is often inaccurate. In this episode, Aleksander Krag (Odense University Hospital) discusses a large Danish study using phosphatidylethanol (PEth), a direct blood biomarker of recent drinking, showing substan ...  Show more

Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection

Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role o ...  Show more

Recommended Episodes

Pancreatic and Hepatobiliary Cancer
Ninja Nerd

Send a textNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob explore pancreatic and hepatobiliary cancers through four patient cases packed with clinical pearls.We begin with a 63-year-old man presenting with painless jaundice, pruritus, and weight loss. Zach wa ...  Show more

Interview: Could we detect breast cancer with a fingerprint? with Dr. Dhivya Srinivasa
TED Health

Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially ground ...  Show more

How MRD Testing is Reshaping Breast Cancer Recurrence Monitoring
OncoTalks | Oncology Insights at Your Fingertips

In this episode of OncoTalks, Dr. Paul Conkling and Dr. Kashif Ali explore how minimal residual disease (MRD) testing using circulating tumor DNA (ctDNA) is reshaping breast cancer management. They discuss how this innovative approach enables the detection of molecular disease ...

  Show more

Episode 008: Metastatic Cancer of “Origin TBD”
The Fellow on Call: The Heme/Onc Podcast

Not to be confused with “carcinoma of unknown primary,” in this episode of metastatic disease of “origin TBD”, we discuss the workup of a mass noted incidentally on imaging. This is a very high yield topic often faced on solid oncology co ...

  Show more